259 related articles for article (PubMed ID: 11686349)
1. Continuous infusion of recombinant factor VIIa: continue or not?
Ewenstein BM
Thromb Haemost; 2001 Oct; 86(4):942-4. PubMed ID: 11686349
[No Abstract] [Full Text] [Related]
2. Elective surgery on factor VIII inhibitor patients using continuous infusion of recombinant activated factor VII: plasma factor VII activity of 10 IU/ml is associated with an increased incidence of bleeding.
Smith MP; Ludlam CA; Collins PW; Hay CR; Wilde JT; Grigeri A; Melsen T; Savidge GF
Thromb Haemost; 2001 Oct; 86(4):949-53. PubMed ID: 11686351
[TBL] [Abstract][Full Text] [Related]
3. Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors.
Santagostino E; Morfini M; Rocino A; Baudo F; Scaraggi FA; Gringeri A
Thromb Haemost; 2001 Oct; 86(4):954-8. PubMed ID: 11686352
[TBL] [Abstract][Full Text] [Related]
4. Use of high dose factor VIIa in hemophilia patients.
Hedner U
Adv Exp Med Biol; 2001; 489():75-88. PubMed ID: 11554593
[No Abstract] [Full Text] [Related]
5. Experiences with continuous infusion of recombinant activated factor VII.
Schulman S; d'Oiron R; Martinowitz U; Pasi J; Briquel ME; Mauser-Bunschoten E; Morfini M; Ritchie B; Goudemand J; Lloyd J; McPherson J; Négrier C; Peerlinck K; Petrini P; Tusell J
Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S97-101. PubMed ID: 9819037
[TBL] [Abstract][Full Text] [Related]
6. Feasibility of using recombinant factor VIIa in continuous infusion.
Schulman S; Bech Jensen M; Varon D; Keller N; Gitel S; Horoszowski H; Heim M; Martinowitz U
Thromb Haemost; 1996 Mar; 75(3):432-6. PubMed ID: 8701403
[TBL] [Abstract][Full Text] [Related]
7. Consensus protocol for the use of recombinant activated factor VII [eptacog alfa (activated); NovoSeven] in elective orthopaedic surgery in haemophilic patients with inhibitors.
Giangrande PL; Wilde JT; Madan B; Ludlam CA; Tuddenham EG; Goddard NJ; Dolan G; Ingerslev J
Haemophilia; 2009 Mar; 15(2):501-8. PubMed ID: 19187194
[TBL] [Abstract][Full Text] [Related]
8. Effective prophylaxis with daily recombinant factor VIIa (rFVIIa-Novoseven) in a child with high titre inhibitors and a target joint.
Saxon BR; Shanks D; Jory CB; Williams V
Thromb Haemost; 2001 Oct; 86(4):1126-7. PubMed ID: 11686341
[No Abstract] [Full Text] [Related]
9. Successful use of recombinant factor VIIa for hemostasis during total knee replacement in a severe hemophiliac with high-titer factor VIII inhibitor.
Carr ME; Loughran TP; Cardea JA; Smith WK; Kuhn JG; Dottore MV
Int J Hematol; 2002 Jan; 75(1):95-9. PubMed ID: 11843300
[TBL] [Abstract][Full Text] [Related]
10. [Treatment and prevention of haemorrhage with recombinant activated factor VII, not only in hemophilia].
Levi M; Friederich PW; van der Meer J
Ned Tijdschr Geneeskd; 2002 Dec; 146(52):2534-7. PubMed ID: 12532665
[TBL] [Abstract][Full Text] [Related]
11. Recombinant activated factor VIIa in uncontrolled bleeding: a haemostasis laboratory study in non-haemophilia patients.
Brandsborg S; Sørensen B; Poulsen LH; Ingerslev J
Blood Coagul Fibrinolysis; 2006 Jun; 17(4):241-9. PubMed ID: 16651865
[TBL] [Abstract][Full Text] [Related]
12. Administration of recombinant activated factor VII in major thoracic operations.
Alavi AA; Jalali SM; Rasouli MR; Eghtesadi-Araghi P
Arch Surg; 2008 Oct; 143(10):1021; author reply 1021. PubMed ID: 18936387
[No Abstract] [Full Text] [Related]
13. Recombinant activated factor VII.
Chin C
Paediatr Anaesth; 2006 Sep; 16(9):907-9. PubMed ID: 16918650
[No Abstract] [Full Text] [Related]
14. Recombinant factor VIIa in multiple surgery.
Schulman S; Lindstedt M; Alberts KA; Agren PH
Thromb Haemost; 1994 Jan; 71(1):154. PubMed ID: 8165636
[No Abstract] [Full Text] [Related]
15. Management of an anti-factor VIII inhibitor occurring during surgical procedure with continuous infusion of Novoseven.
Ménart C; Cognet V; Petit PY; Massignon D; Négrier C
Blood Coagul Fibrinolysis; 1998 Apr; 9(3):289-90. PubMed ID: 9663714
[No Abstract] [Full Text] [Related]
16. Sequential therapy with activated prothrombin complex concentrate (FEIBA) and recombinant factor VIIa in a patient with severe haemophilia A, inhibitor presence and refractory bleeding.
Economou M; Teli A; Tzantzaroudi A; Tsatra I; Zavitsanakis A; Athanassiou-Metaxa M
Haemophilia; 2008 Mar; 14(2):390-1. PubMed ID: 18194305
[No Abstract] [Full Text] [Related]
17. Successful use of recombinant factor VIIa in a haemophiliac with inhibitor undergoing cataract surgery.
Biron-Andréani C; Dupeyron G; Mainemer M; Schved JF
Blood Coagul Fibrinolysis; 2001 Apr; 12(3):215-6. PubMed ID: 11414637
[TBL] [Abstract][Full Text] [Related]
18. rFVIIa and obstructive hydronephrosis.
Louie R; Thomas B; Irwin R
Pediatr Blood Cancer; 2008 Feb; 50(2):431. PubMed ID: 17387704
[No Abstract] [Full Text] [Related]
19. [Perioperative use of recombinant activated factor VII (rF VIIa) in a patient with hemophilia A having inhibitors].
Kawasaki Y; Saeki N; Kawamoto M; Yuge O; Fujii T
Masui; 2005 Aug; 54(8):926-8. PubMed ID: 16104555
[TBL] [Abstract][Full Text] [Related]
20. Continuous infusion of recombinant factor VIIa for surgery in patients with deficiency of factor VII.
Schulman S; Tjønnfjord GE; Wallensten R; Martinowitz U; Kenet G
Thromb Haemost; 2005 Dec; 94(6):1177-80. PubMed ID: 16411390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
